COVID-19 in a Patient With Severe Eosinophilic Asthma on Benralizumab Therapy: A Case Report and Review of Literature
Open Access
- 23 December 2021
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20644
Abstract
Patients with coronavirus disease 2019 (COVID-19) can develop eosinopenia. Eosinophils have various functions, including immunoregulation and antiviral activity, in addition to modulation of an inflammatory reaction. Benralizumab is an anti-interleukin-5Rα monoclonal antibody that selectively depletes eosinophils through enhanced antibody-dependent cell-mediated cytotoxicity. Whether eosinophil depletion affects COVID-19 prognosis is yet to be elucidated. Here, we present a case of a 60-year-old patient with severe asthma on benralizumab therapy, who tested positive for an acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The patient experienced an asymptomatic COVID-19 course without deterioration of asthma control. Eosinophil depletion did not contribute to a deterioration of the clinical status. Comorbidities play a major role in the severity of COVID-19 in patients with asthma. The findings of our case and a literature review revealed that benralizumab therapy is not associated with a significant negative impact on the disease course in COVID-19 patients.Keywords
This publication has 16 references indexed in Scilit:
- COVID-19, severe asthma, and biologicsAnnals of Allergy, Asthma & Immunology, 2020
- Eosinophil responses during COVID-19 infections and coronavirus vaccinationJournal of Allergy and Clinical Immunology, 2020
- COVID-19 in a severe eosinophilic asthmatic receiving benralizumab – a case studyJournal of Asthma, 2020
- Asthma and the Coronavirus Disease 2019 Pandemic: A Literature ReviewInternational Archives of Allergy and Immunology, 2020
- Association of asthma and its genetic predisposition with the risk of severe COVID-19Journal of Allergy and Clinical Immunology, 2020
- Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational StudyAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Eleven faces of coronavirus disease 2019Allergy, 2020
- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, ChinaAllergy, 2020
- Eosinophils: Nemeses of Pulmonary Pathogens?Current Allergy and Asthma Reports, 2019
- Reductions in eosinophil biomarkers by benralizumab in patients with asthmaRespiratory Medicine, 2016